Resectable Rectal Cancer Clinical Stage II and III
1 clinical trials · Condition
◉ Watch Resectable Rectal Cancer Clinical Stage II and III
| Record | Firm | Date |
|---|---|---|
| Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer (NCT01152710) | Institute of Oncology Ljubljana | 2004-06-01 |
Track Resectable Rectal Cancer Clinical Stage II and III automatically
Every clearance here is in the API, with alerts when new ones post.